GlassScriptPhysician profile
Marjorie L Uhalde
NPI 1669568515
$2,015.97
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $778 · 2020: $1,187 · 2021: $30.56 · 2023: $20.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $435.12 | 2019-2020 | |
| Amgen INC. | $303.29 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $220.70 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $194.83 | 2019-2020 | |
| Glaxosmithkline, LLC. | $183.21 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $95.33 | 2019-2020 | |
| Allergan, INC. | $68.14 | 2019-2020 | |
| Pfizer INC. | $54.02 | 2019-2020 | |
| Lilly USA, LLC | $51.89 | 2020 | |
| Eisai INC. | $47.41 | 2020 | |
| Janssen Pharmaceuticals, INC | $46.92 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $46.84 | 2020 | |
| Therapeuticsmd, INC. | $38.02 | 2019 | |
| Novo Nordisk INC | $36.53 | 2020 | |
| Astellas Pharma US INC | $35.68 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $31.98 | 2020 | |
| Lucid Diagnostics INC. | $20.37 | 2023 | |
| Ironwood Pharmaceuticals, INC | $17.14 | 2019 | |
| Collegium Pharmaceutical, INC. | $17.07 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $16.44 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $15.55 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $15.43 | 2019 | |
| Abbott Laboratories | $12.40 | 2019 | |
| Sanofi Pasteur INC. | $11.66 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marjorie Uhalde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.